National Philanthropic Trust’s Revance Therapeutics, Inc. RVNC Stock Holding History

National Philanthropic Trust’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-350,000	Closed	-$1.06M	–	293
2024 Q4	$1.06M	Buy	+350,000	New	+$1.52M	0.02%	173

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

National Philanthropic Trust's RVNC Position: Q1 2025 in Review

National Philanthropic Trust sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 350,000 shares — an estimated $1.06M sold.

National Philanthropic Trust first reported a position in RVNC in Q4 2024 and held it in 1 quarter. The position peaked at $1.06M in Q4 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

National Philanthropic Trust reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
National Philanthropic Trust sold 350,000 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $1.06M.
National Philanthropic Trust first reported a position in Revance Therapeutics, Inc. in Q4 2024 and held it in 1 quarter.
National Philanthropic Trust's Revance Therapeutics, Inc. position peaked at $1.06M in Q4 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on National Philanthropic Trust's 13F filing for Q1 2025, filed 15 May 2026.